Covira Surgical
Publicly observedNorth Chicago, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | North Chicago | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Covira Surgical | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | P955LE4178L5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jan 2023Publicly observed
NIH SBIR/STTR award: A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jan 2023Publicly observed
NIH SBIR/STTR award: A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.